BA in Chemistry, Wesleyan Univ.; MD, Upstate Medical School, State Univ. of NY. More than 20 years as haematologist and medical oncologist. Former Senior VP Millennium Pharmaceuticals. 2006-09, Senior VP, clinical haematology/oncology, Genentech. Concurrently, Adjunct Clinical Professor, Stanford Univ. Aug. 2009, joined Agios as CEO and Member of the Board of Directors. Currently, Adjunct Attending Physician in Haematology, Tufts Medical Center. Since 2012, Member of the Board of Directors, Biotechnology Industry Organization. Member, Board of Directors: Foundation Medicine; bluebird bio; Blueprint Medicines.